The high cost of prescription drugs continues to burden patients and taxpayers. Surveys have shown that about three in ten adults do not take their medicines as prescribed because of the cost. Policymakers and regulators continue to explore various policies and enforcement actions to address the key drivers of high drug prices, address market distortions, and ensure patients and their families can access life-saving treatments. At the same time, challengers are actively pursuing several strategies, including litigation, that could frustrate state and federal measures that address prescription drug affordability.
More Issues
- 340B Program 15 cases
- Affordable Care Act 43 cases
- Anticompetitive Practices 13 cases
- Artificial Intelligence 3 cases
- CARES Act 3 cases
- Consumer Protections 1 cases
- Cost Containment 6 cases
- Equity 11 cases
- ERISA 7 cases
- Inflation Reduction Act 11 cases
- Medicare Advantage 3 cases
- No Surprises Act 26 cases
- Reproductive Health 17 cases
- Site-Neutral Payments 10 cases
- Transparency 5 cases